Inherited Metabolic Diseases in Neurodevelopmental and Neurobehavioral Disorders

Seminars in Pediatric Neurology

Volumn 15, Issue 3, 2008, Pages 127-131

  Kayser, Michael A ^a  

^a Warren Clinics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE INHIBITOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ADENINE; ADENYLOSUCCINATE LYASE; ALLOPURINOL; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; CREATINE; DIHYDROPYRIMIDINE DEHYDROGENASE; GLUCOSE; GLUCOSE TRANSPORTER 1; GUANIDINOACETATE METHYLTRANSFERASE; RIBOSEPHOSPHATE PYROPHOSPHOKINASE; SUCCINATE SEMIALDEHYDE DEHYDROGENASE; URICOSURIC AGENT; VIGABATRIN; XANTHINE OXIDASE INHIBITOR;

AUTISM; BEHAVIOR DISORDER; BLOOD BRAIN BARRIER; BLOOD LEVEL; CEREBRAL PALSY; CLINICAL FEATURE; COGNITIVE DEFECT; DEVELOPMENTAL DISORDER; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; ENZYME DEFICIENCY; GENETIC DISORDER; GLUCOSE TRANSPORT; GOUT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERURICEMIA; INBORN ERROR OF METABOLISM; KETOGENIC DIET; LABORATORY TEST; LEARNING DISORDER; MENTAL DEFICIENCY; METABOLIC DISORDER; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; SEIZURE; TREATMENT INDICATION; URINE LEVEL;

AUTISTIC DISORDER; DIAGNOSIS, DIFFERENTIAL; GUANIDINOACETATE N-METHYLTRANSFERASE; HUMANS; INFANT, NEWBORN; MENTAL RETARDATION; METABOLISM, INBORN ERRORS; MOVEMENT DISORDERS; NEONATAL SCREENING; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE;

EID: 49149092006     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2008.05.006     Document Type: Review

References (37)

1. Stockler S., Holzbah U., Hanefeld F., et al. Creatine deficiency in the brain: A new, treatable inborn error of metabolism. Pediatr Res 36 (1994) 409-413
2. Stockler S., Marescau B., De Deyn P.P., et al. Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis. Metabolism 46 (1997) 1189-1193
3. Von Figura K., Hanefeld F., Isdrandt D., et al. Guanidinoacetate Methyltransferase Deficiency. The Metabolic and Moleculaar Basis of Inherited Diseases (2001), McGraw-Hill, New York, NY 1897-1908
4. Wevers R.A., Engelke U., Wendel U., et al. Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem 41 (1995) 744-751
5. Frahm J., and Hanefeld F. Localized proton magnetic resonance spectroscopy of cerebral metabolites. Neuropediatrics 27 (1996) 64-69
6. Jenne D.E., Olsen A.S., and Zimmer M. The human guanidinoacetate methyltransferase (GAMT) gene maps to a syntenic region on 19p13.3, homologous to band C of mouse chromosome 10, but GAMT is not mutated in jittery mice. Biochem Biophys Res Commun 238 (1997) 723-727
7. Stockler S., Isbrandt D., Hanefeld F., et al. Guanidinoacetate methyltransferase deficiency: The first inborn error of creatine metabolism in man. Am J Hum Genet 58 (1996) 914-922
8. Caldeira Araujo H., Smith W., Verhoeven N.M., et al. Guanidinoacetate methyltransferase deficiency identified in adults and a child with mental retardation. Am J Med Genet A 133 (2005) 122-127
9. Lion-Francois L., Cheillan D., Pitelet G., et al. High frequency of creatine deficiency syndromes in patients with unexplained mental retardation. Neurology 67 (2006) 1713-1714
10. Zugno A.I., Pereira L.O., Mattos C., et al. Guanidinoacetate administration increases acetylcholinesterase activity in striatum of rats and impairs retention of an inhibitory avoidance task. Metab Brain Dis 23 (2008) 189-198
11. Schulze A., Hess T., Wevers R., et al. Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: Diagnostic tools for a new inborn error of metabolism. J Pediatr 131 (1997) 626-631
12. Ganesan V., Johnson A., Connelly A., et al. Guanidinoacetate methyltransferase deficiency: New clinical features. Pediatr Neurol 17 (1997) 155-157
13. Verbruggen K.T., Sijens P.E., Schulze A., et al. Successful treatment of a guanidinoacetate methyltransferase deficient patient: Findings with relevance to treatment strategy and pathophysiology. Mol Genet Metab 91 (2007) 294-296
14. Jakobs C., Bojasch M., Monch E., et al. Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities. The probability of a new inborn error of metabolism. Clin Chim Acta 111 (1981) 169-178
15. Chambliss K.L., Hinson D.D., Trettel F., et al. Two exon-skipping mutations as the molecular basis of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria). Am J Hum Genet 63 (1998) 399-408
16. Jakobs C., Michael T., Jaeger E., et al. Further evaluation of Vigabatrin therapy in 4-hydroxybutyric aciduria. Eur J Pediatr 151 (1992) 466
17. Gibson M.K., and Jakobs C. The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York, NY 2079-2105
18. Gibson K.M., Aramaki S., Sweetman L., et al. Stable isotope dilution analysis of 4-hydroxybutyric acid: An accurate method for quantification in physiological fluids and the prenatal diagnosis of 4-hydroxybutyric aciduria. Biomed Environ Mass Spectrom 19 (1990) 89-93
19. Van den Berghe G., and Jaeken J. The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York, NY 2653-2662
20. Jaeken J., and Van den Berghe G. An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids. Lancet 2 (1984) 1058-1061
21. Stone R.L., Aimi J., Barshop B.A., et al. A mutation in adenylosuccinate lyase associated with mental retardation and autistic features. Nat Genet 1 (1992) 59-63
22. Laikind P.K., Seegmiller J.E., and Gruber H.E. Detection of 5′-phosphoribosyl-4-(N-succinylcarboxamide)-5-aminoimidazole in urine by use of the Bratton-Marshall reaction: Identification of patients deficient in adenylosuccinate lyase activity. Anal Biochem 156 (1986) 81-90
23. Van den Berghe G., and Jaeken J. Adenylosuccinase deficiency. Adv Exp Med Biol 195 (1986) 27-33
24. Jaeken J., Wadman S.K., Suran M., et al. Adenylosuccinase deficiency: An inborn error of purine nucleotide synthesis. Eur J Pediatr 148 (1988) 126-131
25. Becker M.A., Puig J.G., Mateos F.A., et al. Inherited superactivity of phosphoribosylpyrophosphate synthetase: Association of uric acid overproduction and sensorineural deafness. Am J Med 85 (1988) 383-390
26. Garcia-Pavia P., Torres R.J., Rivero M., et al. Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young woman. Arthritis Rheum 48 (2003) 2036-2041
27. Becker M.A., Losman M.J., Rosenberg A.L., et al. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme. Arthritis Rheum 29 (1986) 880-888
28. Becker M.A., Taylor W., Smith P.R., et al. Overexpression of the normal phosphoribosylpyrophosphate synthetase 1 isoform underlies catalytic superactivity of human phosphoribosylpyrophosphate synthetase. J Biol Chem 271 (1996) 19894-19899
29. van Gennip A.H., Abeling N.G., Vreken P., et al. Inborn errors of pyrimidine degradation: Clinical, biochemical and molecular aspects. J Inherit Metab Dis 20 (1997) 203-213
30. Morrison G.B., Bastian A., Dela Rosa T., et al. Dihydropyrimidine dehydrogenase deficiency: A pharmacogenetic defect causing severe adverse reactions to 5-fluorouracil-based chemotherapy. Oncol Nurs Forum 24 (1997) 83-88
31. Gonzalez F.J., and Fernandez-Salguero P. Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency. Trends Pharmacol Sci 16 (1995) 325-327
32. van Gennip A.H., Abeling N.G., Stroomer A.E., et al. Clinical and biochemical findings in six patients with pyrimidine degradation defects. J Inherit Metab Dis 17 (1994) 130-132
33. Duran M., Dorland L., Meuleman E.E., et al. Inherited defects of purine and pyrimidine metabolism: Laboratory methods for diagnosis. J Inherit Metab Dis 20 (1997) 227-236
34. De Vivo D.C., Trifiletti R.R., Jacobson R.I., et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325 (1991) 703-709
35. Wang D., Pascual J.M., Yang H., et al. Glut-1 deficiency syndrome: Clinical, genetic, and therapeutic aspects. Ann Neurol 57 (2005) 111-118
36. Pascual J.M., Wang D., Hinton V., et al. Brain glucose supply and the syndrome of infantile neuroglycopenia. Arch Neurol 64 (2007) 507-513
37. Klepper J., Leiendecker B., Bredahl R., et al. Introduction of a ketogenic diet in young infants. J Inherit Metab Dis 25 (2002) 449-460